Network pharmacology and experimental verification to investigate the mechanism of isoliquiritigenin for the treatment of Alzheimer’s disease
Abstract Isoliquiritigenin (ISL), a flavone isolated from licorice, has been demonstrated to exhibit anti-inflammatory and antioxidant properties in the treatment of Alzheimer’s disease (AD). However, the molecular details of the contribution of ISL to AD remain largely elusive. The present study ai...
Saved in:
Main Authors: | Waimao Gao, Guang Yang, Xinjuan Liu, Kaifan Hu, Jie Pan, Xingyu Wang, Yan Zhao, Ying Xu |
---|---|
Format: | Article |
Language: | English |
Published: |
Nature Portfolio
2025-02-01
|
Series: | Scientific Reports |
Subjects: | |
Online Access: | https://doi.org/10.1038/s41598-025-88542-y |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Danggui-Shaoyao-San Can Ameliorate Alzheimer’s Disease by Inhibiting Hippocampal Neuron Apoptosis: Findings from Serum Pharmacology
by: Zhang KX, et al.
Published: (2025-02-01) -
Neuroprotective role of epigallocatechin-3-gallate, albeginin and melanoxetin in alzheimer's disease
by: Arif Malik, et al.
Published: (2025-02-01) -
α-amanitin induces hepatotoxicity via PPAR-γ inhibition and NLRP3 inflammasome activation
by: Haowei Wang, et al.
Published: (2025-01-01) -
Role of ginsenoside Rg1 as a PPAR-γ activator in protecting against manganese-induced hepatotoxicity: Insights into the TLR4/MyD88/MAPK signaling pathway
by: Mengjing Zhao, et al.
Published: (2025-01-01) -
Editorial: Endocrine disruptors in molecular and structural endocrinology
by: Julianne M. Hall
Published: (2025-02-01)